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calling a national quit line: secondary analyses
from a randomised trial for the utility of ‘urges to
smoke’ measures
Jaspal S Taggar1*, Sarah Lewis2, Graeme Docherty2, Linda Bauld3, Andy McEwen4 and Tim Coleman1Abstract
Background: Single-item urges to smoke measures have been contemplated as important measures of nicotine
dependence This study aimed to prospectively determine the relationships between measures of craving to smoke
and smoking cessation, and compare their ability to predict cessation with the Heaviness of Smoking Index, an
established measure of nicotine dependence.
Methods: We conducted a secondary analysis of data from the randomised controlled PORTSSS trial. Measures of
nicotine dependence, ascertained before making a quit attempt, were the HSI, frequency of urges to smoke (FUTS) and
strength of urges to smoke (SUTS). Self-reported abstinence at six months after quitting was the primary outcome
measure. Multivariate logistic regression and Receiver Operating Characteristic (ROC) analysis were used to assess
associations and abilities of the nicotine dependence measures to predict smoking cessation.
Results: Of 2,535 participants, 53.5% were female; the median (Interquartile range) age was 38 (28–50) years. Both
FUTS and HSI were inversely associated with abstinence six months after quitting; for each point increase in HSI
score, participants were 16% less likely to have stopped smoking (OR 0.84, 95% C.I 0.78-0.89, p < 0.0001). Compared to
participants with the lowest possible FUTS scores, those with greater scores had generally lower odds of cessation
(p across frequency of urges categories=0.0026). SUTS was not associated with smoking cessation. ROC analysis
suggested the HSI and FUTS had similar predictive validity for cessation.
Conclusions: Higher FUTS and HSI scores were inversely associated with successful smoking cessation six months after
quit attempts began and both had similar validity for predicting cessation.
Keywords: Urges to smoke, Smoking cessation, Heaviness of smoking indexBackground
A core feature of drug addiction is the difficulty in redu-
cing or stopping use of substances [1,2]. Tobacco smok-
ing is a major addiction which causes premature
morbidity, mortality and impaired quality of life [3,4],
the risks of which can be reduced by smoking cessation.
However, smokers’ ability to reduce or stop smoking
may be less and their risks of relapse or continued
smoking may be higher when they have higher levels of* Correspondence: Jaspal.taggar@nottingham.ac.uk
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unless otherwise stated.dependence on cigarettes [5]. Consequently, it is import-
ant to have simple, easily-replicable and robust measures
of nicotine dependence, as being able to accurately
measure this crucial quality could help lead greater un-
derstanding of factors associated with successful smok-
ing cessation or continued smoking and perhaps even
lead to more efficient targeting of cessation interventions
[6-8]. There is no single definition of nicotine depend-
ence and consequently there is no universal measure-
ment of it, however, a clinically important consideration
when developing nicotine dependence measures is that
they should have an ability to predict relapse back to
smoking after abstinence [9].This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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commonly used to measure nicotine dependence [10].
Two measures, the Fagerström Test for Nicotine Depend-
ence (FTND) and its shorter derivative, the two-item
Heaviness of Smoking Index (HSI), have been biochem-
ically validated and are widely used in research and clinical
practice [11,12]. These measures predominately rate
smoking behaviour reported by smokers themselves and
higher scores are associated with greater nicotine use and
increased risk of relapse after quitting [13,11,12]. However,
nicotine dependence is likely multi-faceted and subject-
ive symptoms of nicotine dependence are also thought
to be important and have been conceptualised in theor-
ies of dependence [14] such as , the Plans–Responses–
Impulses–Motives–Evaluations (PRIME) theory. PRIME
theory suggests that smokers experience impulses and
motivation to continue smoking [15] and these im-
pulses manifest as cravings or urges to smoke (UTS)
which vary over time in frequency and intensity and
may influence successful smoking cessation [15].
Greater urges or cravings have been found to be asso-
ciated with an increased risk of relapse to smoking [16].
Single-item measures which investigate smokers’ experi-
ences of nicotine withdrawal and which rate the fre-
quency and strength of smokers’ urges to smoke (i.e.
withdrawal symptoms) are brief and easy to administer
[17]; recently [18,19,17], two analyses of survey data
from the Smoking Toolkit Study found that, compared
to the HSI, there was a stronger association between
smokers’ strength of urges to smoke (SUTS) experienced
during a normal smoking day and relapse up to six
months after quitting [20,18,19]. However, frequency of
urges to smoke (FUTS)) was not found to be associated
with relapse to smoking [18,19]. In contrast, an Inter-
national Tobacco Control (ITC) four-country survey in-
vestigated predictors of smoking relapse [21], and found
greater FUTS one month after quitting were associated
with relapse one year later [21]. Although these surveys
included smokers representative of general smoking
populations, there have been no prospective studies that
have tested the generalizability and replicability of find-
ings for the single-item UTS measures to predict abstin-
ence in other smoking populations, such as motivated
smokers that are seeking cessation treatment.
Using data from a smoking cessation quitline trial, we
conducted secondary analyses to prospectively investigate,
within motivated, treatment-seeking smokers, the rela-
tionship between the symptoms of nicotine withdrawal
(i.e. cravings to smoke) and subsequent smoking cessation.
In the same dataset, we investigate the relationship be-
tween HSI, a more established nicotine dependence meas-
ure based on reported smoking behaviour and compare
the utility of this with symptom-based measures for pre-
dicting smoking cessation.Methods
Data sources and study design
Participant data from the Proactive Or Reactive Tele-
phone Smoking CeSsation Support (PORTSSS) trial, a
factorial Randomised Controlled Trial (RCT), were used
as a cohort for this study [22,23]. This tested the efficacy
of proactive telephone support for smoking cessation,
delivered by a publicly-funded English smoking cessation
helpline, in comparison to standard telephone support,
and whether or not additional free Nicotine Replace-
ment Therapy offered via the quitline affected smoking
cessation rates. The protocol, selection criteria and trial
outcomes have previously been reported; briefly the trial
recruited non-pregnant smokers aged 16 or more resid-
ing in England who contacted a quitline, wanted help
with cessation and agreed to set a date for quitting
smoking between four days and four weeks of initial
contact [22,23]. A total of 2,591 participants were rando-
mised. Consent was withdrawn by 56 participants; there-
fore data from 2,535 participants were used for the
current analysis. The characteristics of participants used
for our analyses were similar to those from the
PORTSSS trial. Less than 5% missing data were reported
for each baseline variable.
Measures
Participant characteristics
Data for participant characteristics were collected at
study recruitment and variables used in the analyses in-
cluded: age (years), gender, ethnicity, Index of Multiple
Deprivation (IMD) score (a UK government measure of
deprivation based on income, employment, health
deprivation and disability, education skills and training,
barriers to housing and services, crime and living Environ-
ment; a higher composite score represents greater
deprivation) [24], presence of regular smokers residing in
the same household, entitlement to free prescriptions for
medication, serious attempt to quit smoking made in the
last 12 months, use of any smoking cessation support dur-
ing the last quit attempt, current use of any smoking ces-
sation support and study treatment allocation.
Independent variables
At study entry, (before making a quit attempt) we ascer-
tained from participants’ self-reported i) frequency of
urges to smoke (FUTS) in the last 24 hours [17], ii)
strength of urges to smoke (SUTS) in the last 24 hours
[17] and iii) the Heaviness of Smoking Index (HSI). The
Urges to smoke (UTS) and HSI measures were graded
on six and seven point Likert scales, respectively. FUTS
was ascertained by asking participants “How much of
the time have you felt the urge to smoke in the past
24 hours?” Responses were categorised as 1) not at all,
2) a little of the time, 3) some of the time, 4) a lot of the
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was ascertained by asking participants “How strong have
the urges been in the past 24 hours?” Responses were
categorised as 1) none, 2) slight, 3) moderate, 4) strong, 5)
very strong and 6) extremely strong. The components of
the HSI have been previously reported [12]. Responses of
“don’t know” were coded as missing.Dependant variables [Outcomes]
Smoking status at six months after participants’ quit
date, which was set within four weeks of randomisation
and collection of baseline data in the trial, was used to
determine smoking cessation. For trial outcomes, in ac-
cordance with the Russell standard [25], cessation was
defined as self-reported abstinence or having smoked ≤5
times in total since the quit date and smokers who were
lost to follow-up (n=1,181) were assumed to still be
smoking. This approach to missing data assumes that
data is missing not at random, and specifically that loss
to follow-up equates to continued smoking (or relapse
to smoking), and is standard in smoking cessation trials.
However, we tested in sensitivity analyses an approach
based on an alternative assumption, as described below.Statistical analyses
Analyses were performed using Stata version 11.0. The
prevalence or mean (SD)/median (IQR) of participant
characteristics were calculated for categorical or continu-
ous data, respectively, and compared in those with and
without cessation outcomes. Participant characteristics
were also compared across categories of each measure of
nicotine dependence. Continuous data for participant
characteristics were re-categorised into quintiles in order
to compare participant characteristics and the measures
of dependence. Comparisons were made using students t-
test or analysis of variance (ANOVA) where participant
characteristics were binary variables or consisted of more
than two categories, respectively.
Prior to multivariate modelling the linearity of the nico-
tine dependence measures was assessed by comparing the
bivariate relationship between cessation and each de-
pendence measure fitted in categories or as a continu-
ous variable; differences between the two models were
determined using the likelihood ratio test (LRT) and
nicotine dependence measures were subsequently entered
into multivariate models as categorical or continuous data,
as appropriate. An assessment of multi-collinearity be-
tween the FUTS, SUTS and HIS measures was made
using Variance Inflation factor (VIF) analysis [26]. This
provided an assessment of the degree of independent vari-
ance amongst the variables and a single VIF > 10 or toler-
ance (1/VIF) < 0.1 was used to indicate the presence of
substantial collinearity.Logistic regression adjusting a priori for age, gender and
treatment group was used to determine the association
between each measure of nicotine dependence and smok-
ing cessation at six months with the primary analysis
using the assumption that loss to follow up was equivalent
to a participant having returned to smoking [27]. An
assessment for other confounding variables (ethnicity,
IMD score, smoker residing in same household, free
entitlement to NHS prescriptions, quit attempt in last
12 months, cessation support used in last 12 months,
cessation support used in last quit attempt and current
use of cessation support) was made and, any identified,
were included in the multivariate model as appropriate;
a significant confounder was defined as a covariate sig-
nificantly associated with both the measure of nicotine
dependence and outcome, and one that altered the uni-
variable association between these by ≥10%. To determine
if the association between dependence measures and out-
comes was modified according to categories of age or gen-
der, an assessment of interaction by these variables was
made using the LRT. Throughout all analyses the signifi-
cance of associations was determined using the Wald test,
for binary variables, or LRT for categories and trend, for
categorical and ordinal variables, respectively. A p value
of <0.05 indicated statistical significance. The ability of
the UTS and HSI measures to predict smoking cessa-
tion was determined using Receiver Operating Charac-
teristic (ROC) analysis [28]. The multivariate model for
each statistically significant association between meas-
ure of dependence and outcome was entered separately
into ROC models. An assessment of study power found
the dataset had a 90% power to detect an association
between the measures of nicotine dependence and
smoking cessation at the 5% significance level.
To investigate the appropriateness of our assumption
that those lost to follow up were still smoking, we con-
ducted a multiple imputation sensitivity analysis based
on the alternative assumption that outcome data were
missing at random. We used the mi commands in Stata
and all baseline variables in the imputation model (20
imputations). Logistic regression, adjusting for the same
variables as in the primary analyses, was used to deter-
mine the associations between measures of dependence
and smoking cessation. The statistical significance of as-
sociations was determined using the joint Wald’s test.
Differences between the principal and sensitivity ana-
lyses were compared and important differences are com-
mented on qualitatively.
Results
Participant characteristics and their associations with
measures of nicotine dependence
Of the 2,535 participants the median (IQR) age and IMD
scores were 38 (28–50) and 23.1 (13.5-37.1), respectively;
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Caucasian. The UTS and HSI measures were normally
distributed; the mean (SD) FUTS, SUTS and HSI
scores were 4 (1.2), 4 (1.1) and 3 (1.6), respectively. Of
all participants, 469 (18.5%) reported abstinence at six
months. There were 1,354 (53.4%) participants that
provided data for cessation outcomes at six months.
Participants lost to follow up were younger (median (IQR)
age: 35 (25–46) versus 40 (30–53), Mann- Witney test
p < 0.0001), experienced greater social deprivation (me-
dian (IQR) IMD score: 24 (14.1-38.3) versus 22.1 (13.0-
37.7), Mann–Whitney test p=0.0382) and had greater HSI
scores (mean (SD) HSI score: 3.3 (1.6) versus 3.1 (1.6),
Students t-test p=0.0042; d.f 2509) than those who pro-
vided follow up data for smoking status (Additional file 1:
Table S1).
The associations between participant characteristics
and measures of dependence are presented in Table 1.
The mean FUTS and SUTS scores were similar across
quintiles of ascending age. However, the mean (SD) HIS
score significantly increased from 2.9 (1.5) to 3.5 (1.5) in
participants with the lowest to highest age quintile, re-
spectively. There were no significant differences in mean
scores of the dependence measures across categories of
gender. Greater IMD scores were associated with signifi-
cantly higher ratings of the HSI; participants in the low-
est quintile of IMD score reported a mean (SD) HSI
score of 2.9 (1.6) and this increased to 3.5 (1.5) in those
categorised to the highest IMD quintile. Participants res-
iding in the same household as smokers were more
likely to report greater FUTS and HSI scores than those
living without other smokers. Greater FUTS, SUTS and
HIS scores were reported in participants entitled to free
NHS prescriptions and those who reported using cessa-
tion support during their last quit attempt. The mean
FUTS, SUTS and HSI scores for those entitled to free
NHS prescriptions were 3.6 (1.2), 3.6 (1.2) and 3.4 (1.5),
respectively. There were no significant differences in the
scores of all dependence measures according to the
PORTSS study treatment allocation.
Multivariate modelling
The VIF and tolerance for the FUTS, SUTS and HSI
measures were less than 10 and above 0.1; consequently,
there was substantial collinearity between the measures
of nicotine dependence. The associations between par-
ticipant characteristics and smoking cessation are pre-
sented in Additional file 1: Table S2. Of variables that
were significantly associated with both measure of de-
pendence and smoking cessation, none adjusted the uni-
variate odds ratio by ≥10% (Additional file 1: Table S3).
Therefore, age, gender and study treatment group were
retained in multivariate analyses by a priori justification.
Age and IMD score were retained as continuous measuresas there were no significant differences between the cate-
gorised and continuous variables. A linear relationship for
the associations between SUTS and HSI measures and
outcomes were found. In contrast, the relationship be-
tween FUTS and smoking cessation was non-linear (LRT
p=0.0306; d.f=4). However, the findings have been re-
ported as categorised and continuous variables for all
measures of dependence to enable the comparison of find-
ings with previous research [18,19]. The associations be-
tween the dependence measures and smoking cessation
were not modified by age and gender.
Association and predictive abilities of the measures of
nicotine dependence for smoking cessation
The associations and predictive abilities of nicotine de-
pendence measures for smoking cessation are presented
in Table 2. As a continuous measure, every one-point in-
crease in HSI was associated with a 16% (OR 0.84, 95%
C.I 0.78-0.89; LRT p < 0.0001; d.f=1) reduction in the
odds of smoking cessation six months after quitting. In
contrast, every point increase in SUTS was associated
with a non-significant 8% reduction in smoking cessa-
tion (OR 0.92, 95% C.I 0.84-1.02; LRT p=0.1000; d.f=1).
As compared to those with the lowest FUTS (category
1), participants were initially more likely to report ab-
stinence in the lower categories of FUTS (categories 2
and 3), but then as time spent with urges increased (cat-
egory 5) participants were less likely to report cessation
[(OR (95% C.I) for cessation in categories 2 and 5 of
FUTS 1.35 (0.73-2.49) and 0.64 (0.33-1.22), respectively,
LRT p for categories=0.0026); d.f=5]. The abilities to
predict cessation for the HSI as a continuous variable
[AUC (95% C.I)=0.63 (0.60-0.66)] and FUTS as a cate-
gorised variable [AUC (95% C.I)=0.63 (0.60-0.66)] mea-
sures were similar.
The results from the multiple imputation analyses are
presented in Table 3. These findings from multivariate
analyses were essentially the same as those from our pri-
mary analyses and FUTS and the HSI were significantly
associated with cessation six months after participants
quit smoking. The SUTS measure was not associated
with abstinence. As a continuous measure, each point
increase in the HSI score was association with a 15% re-
duction in the odds of smoking cessation at six months
(OR 0.85 (95% C.I 0.79-0.92). The association between
FUTS and smoking cessation was non-linear and, as
compared to participants with the lowest score (category
1), those with higher FUTS (category 5) were 38% less
likely to report abstinence (OR (95% C.I) for category 5
of FUTS 0.62 (0.27-1.39).
Discussion
In a sample of smokers who sought smoking cessation
support and participated in a trial set within a quitline,
Table 1 Associations between participant characteristics and the measures of nicotine dependence
VARIABLE FUTS SUTS HSI
Mean (s.d) d.f P-value Mean (s.d) d.f P-value Mean (s.d) d.f P-value
Age
Quintile 1 3.5 (1.1) 4; 2414 0.3035 3.6 (1.1) 4 0.9768 2.9 (1.5) 4 <0.01
Quintile 2 3.4 (1.1) 3.5 (1.1) 2.7 (1.6 )
Quintile 3 3.5 (1.2) 3.6 (1.2) 3.3 (1.5)
Quintile 4 3.6 (1.2) 3.6 (1.1) 3.6 (1.6)
Quintile 5 3.5 (1.2) 3.6 (1.1) 3.5 (1.5)
Gender
Male 3.5 (1.2) 2439 0.6899 3.5 (1.1) 2439 0.2456 3.2 (1.6) 2466 0.2637
Female 3.5 (1.1) 3.6 (1.1) 3.2 (1.6)
Ethnicity
White 3.5 (1.2) 3; 2480 0.7406 3.6 (1.1) 3 0.7051 3.2 (1.6) 3 <0.01
Black/mixed 3.5 (1.2) 3.7 (1.2) 2.8 (1.6)
Asian/mixed 3.5 (1.3) 3.5 (1.0) 2.7 (1.6)
Other 3.4 (1.3) 3.7 (1.3) 3.2 (1.6)
IMD score
Quintile 1 3.4 (1.2) 4; 2479 0.0618 3.6 (1.2) 4 0.1203 2.9 (1.6) 4 <0.01
Quintile 2 3.5 (1.2) 3.5 (1.1) 3.0 (1.6 )
Quintile 3 3.5 (1.1) 3.6 (1.1) 3.2 (1.6)
Quintile 4 3.5 (1.2) 3.5 (1.1) 3.4 (1.5)
Quintile 5 3.6 (1.2) 3.7 (1.2) 3.5 (1.5)
Smoker in same household
No 3.5 (1.2) 3.5 (1.1) 3.2 (1.6)
Yes 3.6 (1.2) 2478 <0.05 3.6 (1.1) 2478 0.2063 3.3 (1.6) 2505 <0.05
Free prescription entitlement
No 3.4 (1.1) 3.4 (1.1) 2.9 (1.6)
Yes 3.6 (1.2) 2456 <0.01 3.6 (1.2) 2456 <0.01 3.4 (1.5) 2483 <0.01
Quit attempt in last 12 months
No 3.5 (1.2) 3.5 (1.1) 3.2 (1.6)
Yes 3.6 (1.1) 2476 0.0621 3.7 (1.1) 2475 <0.01 3.2 (1.6) 2501 0.2932
Cessation support last quit attempt
No 3.5 (1.2) 3.5 (1.1) 3.1 (1.6)
Yes 3.7 (1.1) 2482 <0.01 3.7 (1.1) 2482 <0.01 3.4 (1.5) 2509 <0.01
Current cessation support
No 3.5 (1.2) 2.5 (1.1) 3.2 (1.6)
Yes 3.6 (1.2) 2482 0.2969 3.6 (1.1) 2482 0.3838 3.4 (1.5) 2509 <0.01
Trial intervention
Reactive support without NRT 3.6 (1.2) 3 0.7149 3.5 (1.2) 3 0.6796 3.2 (1.6) 3 0.9512
Reactive support with NRT 3.5 (1.1) 3.6 (1.1) 3.2 (1.6)
Proactive support without NRT 3.5 (1.2) 3.5 (1.1) 3.2 (1.6)
Proactive support with NRT 3.5 (1.2) 3.6 (1.1) 3.2 (1.6)
FUTS = Frequency of urges to smoke; SUT=Strength of urges to smoke; HSI=Heaviness of smoking Index; s.d=standard deviation d.f=degrees of freedom – values
provided are for the model and residual; IMD=Index of Multiple Deprivation
With the exception of age, ethnicity and IMD score, all significance testing between participant characteristics and measures of dependence conducted using
Students t-test. Significance testing for age, ethnicity and IMD score conducted using Analysis of Variance (ANOVA).
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Table 2 Associations and predictive abilities of nicotine dependence measures and smoking cessation
N=2,535 UNIVARIATE MULTIVARIATE† ROC ANALYSIS
OR (95% C.I) P VALUE (d.f)‡ OR (95% C.I) P VALUE (d.f)‡ AUC (95% C.I) P VALUE** (d.f)
FUTS CONTINUOUS 0.89 (0.81-0.97) 0.0067 (1) 0.88 (0.81-0.97) 0.0076 (1) 0.62 (0.59-0.64) 0.0769 (1)
SUTS CONTINUOUS 0.92 (0.84-1.01) 0.0747 (1) 0.92 (0.84-1.02) 0.1000 (1) n/e
HSI CONTINUOUS 0.88 (0.82-0.93) <0.0001 (1) 0.84 (0.78-0.89) <0.0001 (1) 0.63 (0.60-0.66)
FUTS CATEGORISED
1 1 <0.01 (5) 1 0.0026 (5) 0.63 (0.60-0.66) 0.2828 (1)
2 1.14 (0.64-2.02) 1.35 (0.73-2.49)
3 1.19 (0.69-2.04) 1.39 (0.78-2.46)
4 0.92 (0.54-1.59) 1.10 (0.62-1.96)
5 0.55 (0.30-1.03) 0.64 (0.33-1.22)
6 0.98 (0.51-1.90) 1.05 (0.52-2.13)
SUTS CATEGORISED
1 1 0.2693 (5) 1 0.3764 (5) n/e
2 0.98 (0.56-1.74) 1.16 (0.63-2.12)
3 0.97 (0.59-1.61) 1.15 (0.67-1.97)
4 0.99 (0.60-1.64) 1.09 (0.63-1.86)
5 0.76 (0.43-1.32) 0.87 (0.48-1.57)
6 0.57 (0.28-1.18) 0.70 (0.33-1.48)
HSI CATEGORISED
0 1 <0.01 (6) 1 <0.0001 (6) 0.64 (0.61-0.67)
1 0.97 (0.60-1.57) 1.05 (0.63-1.74)
2 1.01 (0.65-1.58) 0.98 (0.61-1.58)
3 0.76 (0.49-1.17) 0.78 (0.49-1.23)
4 0.76 (0.49-1.17) 0.70 (0.44-1.11)
5 0.60 (0.38-0.97) 0.52 (0.31-0.86)
6 0.37 (0.20-0.69) 0.26 (0.13-0.51)
†adjusted for age, gender and treatment group [n=2,377 and n=2,404 for sample size retained in analyses for FUTS/SUTS and HSI, respectively]; ‡ Likelihood Ratio
Test p value; **Chi-squared test p value; d.f=degrees of freedom
OR=Odds Ratio; C.I = confidence interval; FUTS = frequency of urges to smoke; SUTS = strength of urges to smoke; HSI = heaviness of smoking index; ROC = Receiver
Operating Characteristic; AUC = Area under ROC curve; n/e = not entered into the ROC analysis model.
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likely to report smoking abstinence six months after
quitting. For each point increase in HSI score partici-
pants were 16% less likely to remain abstinent. In
addition, participants who experienced the greatest time
spent with urges were 36% less likely to report cessation
when compared to those with the least FUTS. Both
FUTS and the HSI measures had similar predictive abil-
ities for smoking cessation. The SUTS measure was not
associated with abstinence in smokers who called a quit-
line for cessation support, which contrasts with the find-
ings from previous research in other smoking populations
[18,19].
Strengths and Limitations
To our knowledge this is the largest study that has in-
vestigated the association between UTS and smokingcessation and the first such study conducted in moti-
vated smokers who have sought quitline support . Fur-
thermore, our findings were strengthened by the use of
prospectively collected data, which enabled the temporal
relationship between dependence measures and cessation
outcomes to be investigated. Although only 1,354 (53.4%)
participants provided follow-up data at six months our
study used an intention to treat analysis and participants
lost to follow up were assumed to be smokers. We ex-
plored the validity of this assumption by conducting, as a
sensitivity investigation, a multiple imputation analysis
that assumed outcome data were missing at random; there
were no substantial differences between the findings from
sensitivity and primary analyses.
Previous studies have investigated the single-item UTS
measures as continuous variables [19,21,29,16] and as-
sume their relationship with abstinence is linear. This is
Table 3 Multiple imputation analyses for associations of nicotine dependence measures and smoking cessation
MULTIVARIATE†
OR (95% C.I) P VALUE‡ Degrees of freedom
FUTS CONTINUOUS 0.89 (0.80-0.99) 0.0271 Min: 94.1; Av: 115.4; Max: 162.3
SUTS CONTINUOUS 0.94 (0.86-1.04) 0.2334 Min: 103.1; Av: 126.7; Max: 166.9
HSI CONTINUOUS 0.85 (0.79-0.92) <0.0001 Min: 101.8; Av: 122.8; Max: 164.0
FUTS CATEGORISED
1 1 0.0186 Min: 56.6; Av: 90.9; Max: 165.0
2 1.31 (0.60-2.89)
3 1.34 (0.64-2.82)
4 1.09 (0.54-2.20)
5 0.62 (0.27-1.39)
6 0.98 (0.41-2.34)
SUTS CATEGORISED
1 1 0.6436 Min: 51.6; Av: 103.0; Max: 169.6
2 1.23 (0.62-2.42)
3 1.21 (0.62-2.38)
4 1.09 (0.60-2.01)
5 0.96 (0.43-2.11)
6 0.78 (0.36-1.71)
HSI CATEGORISED
0 1 0.0003 Min: 86.0; Av: 122.4; Max: 213.7
1 1.10 (0.63-1.95)
2 0.95 (0.55-1.66)
3 0.79 (0.48-1.32)
4 0.83 (0.50-1.39)
5 0.54 (0.31-0.95)
6 0.25 (0.13-0.48)
†adjusted for age, gender, treatment group; ‡ Joint Wald test Test p value; OR = Odds Ratio; C.I = confidence interval; FUTS = frequency of urges to smoke; SUTS =
strength of urges to smoke; HSI = heaviness of smoking index; Min =minimum; Av = average; Max =maximum.
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both categorical and continuous variables. An unex-
pected finding was the non-linear relationship between
FUTS and abstinence, which limited our ability to dir-
ectly compare the relationship for HSI and FUTS mea-
sures to smoking cessation.
Our study collected data from the NHS smoking help-
line as part of a RCT and the demography of participants
was similar to that reported of people who set quit dates
through community-based NHS stop smoking services
[30]. This suggests that our findings may be representa-
tive of smokers who seek help with cessation generally.
However, there was little ethnic diversity in the study
population, so caution is needed when applying our find-
ings to populations with higher proportions of ethnic
minority groups.
Outcomes were not biochemically verified and the
ascertainment of self-reported measures may have intro-
duced recall and reporting bias resulting in the over-reporting of cessation [31]. However, the PORTSSS trial
research staff were trained to encourage participants to
provide honest accounts and any bias in reports of smok-
ing status are likely to have been minimised [23,22].
Although we adjusted for the effects of confounding
by the variables age, gender and treatment group from
the PORTSSS trial, there are other factors that, in other
studies, have been found to be associated with the suc-
cess of quit attempts and for which data were not avail-
able. For example, the mental health status of smokers
and baseline motivation to quit [27,32,33] have been re-
ported as predictors of outcomes after quitting and such
factors may also be associated with measures of nicotine
dependence. Furthermore, we did not have data for
other factors that may have influenced our findings such
as other substance misuse and years of nicotine use. The
potential for residual confounding, therefore, remains a
possibility and could influence the observed associations
in either direction and future research investigating the
Taggar et al. Substance Abuse Treatment, Prevention, and Policy  (2015) 10:15 Page 8 of 10construct of nicotine dependence should ideally account
for these variables.
Comparison with previous research
Previous studies that investigated the association be-
tween single-item urges to smoke measures and cessa-
tion used data from the Smoking Toolkit Study (STS)
and International Tobacco Control (ITC) four country
survey; these studies involved a longitudinal design using
repeat cross-sectional survey and included participants
that were older, less nicotine dependent and more likely
to be female than in our study [19,21,29,34]..
The first analysis from the STS found, as compared to
the HSI, SUTS were most strongly associated with and
had the greatest validity for predicting abstinence. Higher
pre-quit SUTS was associated with a greater chance of re-
lapse up to six months after quitting [18]. However, FUTS
was not associated with abstinence. The second analysis
from the STS investigated the association between smok-
ing dependence and self-reported smoking status six
months later [19]; greater SUTS were associated with a re-
duction in both abstinence and the chance of being a
non-smoker six months later. In our study, both the HSI
and FUTS measures were associated with and predictive
of abstinence. SUTS, however, was not significantly associ-
ated with smoking cessation. Although the STS included a
representative sample of English smokers the findings are
not necessarily generalizable to other populations, such as
smokers seeking cessation support. The contrasting find-
ings may reflect differences in study populations, with our
study including only motivated smokers who were seeking
quitline support. However, it is difficult to think of a lo-
gical reason why, in one sample of smokers the perceived
strength of urges should be predictive of cessation,
whereas in the other, the frequency with which these were
recalled was more important. It remains possible, there-
fore, that these divergent findings could arise due to in-
stability and low reliability of the single-item measures
used to measure the two constructs [35].
To date, there has only been one study that has com-
pared the predictive ability of UTS with a validated
measure of nicotine addiction [18]. Findings from the
STS suggested that, based on the magnitude of associ-
ation, SUTS had the greater ability to predict abstinence
up to six months after quitting as compared to the HSI.
Our study is the first to report the predictive abilities of
UTS measures using ROC analyses; this enabled com-
parisons to be made between the categorical FUTS and
continuous HSI variables, and enables the cut-off point
of each measure to be evaluated for predicting out-
comes. Both FUTS and the HSI measures were found to
predict abstinence, which contrasts with the findings
from previous research that included smokers who are
not necessarily seeking help with cessation [18]. Ourfindings from ROC analyses were consistent with those
from a study by Courvoisier and colleagues [13] who
compared the abilities of several, non urges to smoke,
nicotine dependence measures to predict abstinence
31 days after quitting, in smokers who accessed a cessa-
tion website. The authors reported that HSI had an abil-
ity to predict abstinence that was similar to our ROC
findings which strengthens their validity. However, our
study reports the predictive ability of the HSI for smok-
ing cessation six months after quitting which conflicts
with recent findings from the ITC four country survey
[36]; Yong and colleagues reported that, although the
HSI is predictive of short term relapse, it is not predict-
ive of cessation beyond one month after quitting, and
the contrasting findings may reflect differences in the
populations between our study - that specifically in-
cluded treatment seekers - and the ITC four country
survey.
Most craving assessment tools focus on the strength of
cravings experienced [35]. However, the severity of crav-
ing fluctuates throughout the course of a normal day
and, as the SUTS measure ascertains the severity of
cravings experienced by smokers in the past 24 hours,
the lack of association between SUTS and abstinence
may reflect the greater day-to-day instability and lower
reliability of this single-item measure [35]. It has been
suggested that the assessment of urge frequency may in-
crease the yield of dependence measures for predicting
cessation and this may have a greater utility when com-
bined with other measures of cravings [35]. Further-
more, the findings for FUTS and the HSI in our study
could reflect an overlap in the hypothetical construct of
these measures; smokers who experience a greater urge
frequency may smoke more over a typical day, although
the analyses in the current study suggest there was no
substantial collinearity amongst the measures of nicotine
dependence.
Our study investigated the relationship between pre-
quit measures of dependence and smoking cessation. A
recent systematic review investigated the relationship be-
tween cravings and smoking cessation, and found the
timing of craving assessment influences the success of
smoking cessation [37]. Wray and colleagues found, as
compared to studies where pre-quit cravings were
assessed, studies that measured cravings after a quit at-
tempt was initiated were more likely to detect an associ-
ation for predicting abstinence. It is possible that
cravings experienced by smokers before quitting are
conceptually different to those after initiation of a quit
attempt. Before quitting, smokers who are regularly
smoking are likely to report a lower intensity of craving;
therefore, pre-quit craving assessment, as in the current
study, may be subject to floor effects reducing the
strength of observed associations [37]. However, in our
Taggar et al. Substance Abuse Treatment, Prevention, and Policy  (2015) 10:15 Page 9 of 10study the mean baseline FUTS, SUTS and HSI scores
were at the mid-point of respective scales and the im-
pact of floor effects is likely to be minimised.
Conclusions
FUTS and the HSI were associated with and had a similar
predictive ability for relapse six months after smokers
made an attempt to quit. Single-item UTS measures are
brief, easy to administer and may be pragmatic to measure
the craving component of nicotine addiction. However,
further research that tests the reproducibility, day-to-day
stability and utility of combining the UTS as multi-item
measures in other smoking cessation settings is required
to provide a greater understanding of the role of these
measures in the construct of nicotine addiction.
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